학술논문

Daratumumab in first-line treatment of patients with light chain amyloidosis and Mayo stage IIIb improves treatment response and overall survival
Document Type
Article
Source
In: Haematologica. (Haematologica, January 2024, 109(1):220-230)
Subject
Language
English
ISSN
15928721
03906078